Table 2.

Primary patency with retrievable scaffold therapy in combination with sirolimus-coated balloon angioplasty compared to meta-analysis-derived estimates with DCB and PTA in Infrapopliteal arteries

Study	6 months	1 year
RST + sirolimus DCB
Current study	91%	90%
DCB
Guo [2022] [20]	68%	74%
Giannopoulos [2020] [22]	†	64%
Ipema [2020] [21]	†	67% *
PTA
Snyder [2023] [19]	68%	66%
Guo [2022] [20]	35%	27%
Nugteren [2022] [8]	†	59%
Ipema [2020] [21]	†	38% *
Romiti [2008] [4]	65%	58%

^*Values are restenosis rates; primary patency was not reported.

^†Values not reported.

DCB, drug-coated balloon; PTA, percutaneous transluminal angioplasty; RST, retrievable scaffold therapy.